View in EDS HTML Full Text PDF Full Text

A phase Ia study of a novel anti-HER2 antibody–drug conjugate GQ1001 in patients with previously treated HER2 positive advanced solid tumors.

Saved in:
Bibliographic Details
Title: A phase Ia study of a novel anti-HER2 antibody–drug conjugate GQ1001 in patients with previously treated HER2 positive advanced solid tumors.
Authors: Zhou, Chenfei1 (AUTHOR), Wang, Bin2 (AUTHOR), Teng, Christina3 (AUTHOR), Yang, Hui1 (AUTHOR), Piha-Paul, Sarina A.4 (AUTHOR), Richardson, Gary5 (AUTHOR), Malalasekera, Ashanya6 (AUTHOR), Sun, Yajun7 (AUTHOR), Wang, Wei2 (AUTHOR), Liu, Jieqiong8 (AUTHOR) liujieqiong01@163.com, Shi, Yan1 (AUTHOR) shibaiwan12@vip.sina.com, Zhan, Xianbao2 (AUTHOR) zhanxianbao@csco.org.cn, Lemech, Charlotte3 (AUTHOR) charlotte.lemech@scientiaclinicalresearch.com.au
Source: Journal of Translational Medicine. 1/9/2025, Vol. 23 Issue 1, p1-11. 11p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:14795876
DOI:10.1186/s12967-024-05985-z